[{"AccountsPayableCurrent_0_Q2_USD":9927000.0,"MarketableSecuritiesCurrent_0_Q2_USD":515476000.0,"ConvertibleDebtNoncurrent_0_Q2_USD":348842000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-69000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":161000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2_Q2_USD":52500000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":318596000.0,"RestrictedCashCurrent_0_Q2_USD":1248000.0,"OtherAssetsCurrent_0_Q2_USD":1828000.0,"IncreaseDecreaseInOtherCurrentAssets_2_Q2_USD":824000.0,"PaymentsToAcquireAvailableForSaleSecurities_2_Q2_USD":567188000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-842000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":552000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":3029000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":0.0,"DeferredIncomeTaxExpenseBenefit_1_Q2_USD":0.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":483000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":-681000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-681000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-286956000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-119298000.0,"AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_1_Q2_USD":122147000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":9986000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-9570000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":11489000.0,"OtherAssetsNoncurrent_0_Q2_USD":906000.0,"AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1_Q2_USD":35000.0,"DerivativeGainLossOnDerivativeNet_1_Q2_USD":2770000.0,"RestrictedCash_0_Q2_USD":1248000.0,"ProceedsFromStockPlans_2_Q2_USD":521000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.083,"OperatingLeaseRightOfUseAsset_0_Q2_USD":12959000.0,"OperatingLeasePayments_2_Q2_USD":2056000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":10735000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":2664000.0,"OperatingLeaseLiability_0_Q2_USD":13399000.0,"OperatingLeaseCost_2_Q2_USD":2000000.0,"OperatingLeaseCost_1_Q2_USD":1000000.0,"LongTermPurchaseCommitmentAmount_2_Q2_USD":14100000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":2670000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":1872000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":3519000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":3283000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":3288000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q2_USD":4107000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":16069000.0,"InvestmentIncomeNonoperating_2_Q2_USD":3300000.0,"InvestmentIncomeNonoperating_1_Q2_USD":1025000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":518000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-20000.0,"DerivativeGainLossOnDerivativeNet_2_Q2_USD":-65636000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-33389000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":334000.0,"CurrentIncomeTaxExpenseBenefit_2_Q2_USD":0.0,"PrepaidExpenseCurrent_0_Q2_USD":17925000.0,"NetIncomeLoss_2_Q2_USD":-287439000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-202643000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-515661000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":684935000.0,"LiabilitiesCurrent_0_Q2_USD":57990000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":870106000.0,"Liabilities_0_Q2_USD":638042000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":1600000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":57918000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":28414000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-3.85,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-1.57,"Depreciation_2_Q2_USD":180000.0,"CommonStockValue_0_Q2_USD":8000.0,"CommonStockSharesOutstanding_0_Q2_shares":75600000.0,"CommonStockSharesIssued_0_Q2_shares":75600000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":317348000.0,"AssetsCurrent_0_Q2_USD":853825000.0,"Assets_0_Q2_USD":870106000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":25358000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":25358000.0,"AdditionalPaidInCapital_0_Q2_USD":1100639000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":329000.0,"NetIncomeLoss_1_Q2_USD":-118617000.0,"CurrentIncomeTaxExpenseBenefit_1_Q2_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":973000.0,"ProfitLoss_2_Q2_USD":-287439000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":20000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":5000.0,"IncreaseDecreaseInPrepaidExpense_2_Q2_USD":-1877000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":1355000.0,"ShareBasedCompensation_2_Q2_USD":20783000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":156377000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":87094000.0,"PreferredStockValue_0_Q2_USD":0.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"OperatingIncomeLoss_2_Q2_USD":-214295000.0,"OperatingIncomeLoss_1_Q2_USD":-115508000.0,"InterestPaidNet_2_Q2_USD":3829000.0,"CommonStockSharesAuthorized_0_Q2_shares":200000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"AccruedLiabilitiesCurrent_0_Q2_USD":45399000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":74635.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":75550.0,"StockholdersEquity_0_Q2_USD":232064000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-868912000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":2416000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":381423000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":521000.0,"Ticker":"APLS","CIK":"1492422","name":"APELLIS PHARMACEUTICALS, INC.","OfficialName":"Apellis Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"5553923312.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200730"}]